PIPELINE

Discover our latest research on IDO pathway inhibitors, indoximod and NLG802 Read More

MANAGEMENT

Meet our dedicated team of professionals Read More

INVESTORS

Find up-to-date financial data and latest press releases Read More

Press Releases

More releases
<!-- --!>